Arrow Fat Left Icon Arrow Fat Right Icon Arrow Right Icon Cart Icon Close Circle Icon Expand Arrows Icon Facebook Icon Twitter Icon Youtube Icon Hamburger Icon Information Icon Down Arrow Icon Mail Icon Mini Cart Icon Person Icon Ruler Icon Search Icon Shirt Icon Triangle Icon Bag Icon Play Video
We've Moved! Coding Leader is now Healthcare Training Leader. Visit us at www.HCTrainingLeader.com We've Moved! Coding Leader is now Healthcare Training Leader. Visit us at www.HCTrainingLeader.com
  • Coverage of Hep B Screening With FDA Approved Tests
  • Post author
    Lacy Gaskins

Coverage of Hep B Screening With FDA Approved Tests

The Centers for Medicare & Medicaid Services (CMS) requests that Medicare Administrative Contractors (MACs) work to accommodate CMS coverage of Hepatitis B screening for non-pregnant, high risk individuals with the appropriate U.S. Food and Drug Administration (FDA) approved/cleared laboratory tests. The coverage is compliant with Clinical Laboratory Improvement Act (CLIA) regulations.

Full Transmittal: https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/2017Downloads/R3804CP.pdf

Subject: Screening for Hepatitis B Virus (HBV) Infection

Number: 3804

Title: 9859

Release Date: June 29, 2017

Effective Date: September 8, 2016

Implementation Date: October 2, 2017

Special Notes: Transmittal 197, Pub. 100-03, and Transmittal 3793, Pub. 100-04 dated June 9, 2017, are being rescinded and replaced by Transmittals 3804 and Transmittal 3804 dated June 29, 2017 to correct the verbiage in split release dates to state the following: October 2, 2017 analysis and design. January 2, 2018 Testing and implementation. All other information remains the same.

  • Post author
    Lacy Gaskins